Characterization and Chromatographic Isolation of Platelet Extracellular Vesicles from Human Platelet Lysates for Applications in Neuroregenerative Medicine
- 30 November 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 7 (12) , 5823-5835
Abstract
Human platelet lysates (HPLs) made from clinical-grade platelet concentrates are currently evaluated in the preclinical models of Parkinson’s disease, Alzheimer’s disease, traumatic brain injury, and others, as a new polyvalent neuroprotective biotherapy of the central nervous system. However, the presence and content of extracellular vesicles (EVs) in HPLs and their potential contribution to the neuroprotective and neurorestorative activities of HPLs are still unknown. We, therefore, characterized the EVs present in four different HPL preparations and after purification by size-exclusion chromatography. We then tested the effect of the isolated EVs on neuronal cell repair. We identified that all four HPLs contained a high and similar amount of EVs (1011 to 1012/mL) with a mean size ranging from ca. 50 to 300 nm and a negative zeta potential as determined by nanoparticle tracking analysis and dynamic light scattering. Western blot analysis revealed that the EVs present in HPLs expressed the clusters of differentiation 41 (CD41) and 61 (CD61) characteristic of platelets. These EVs were efficiently isolated from HPL proteins by Sepharose CL-2B size-exclusion column chromatography as confirmed by total protein determination and protein profile by sodium dodecyl sulfate polyacrylamide gel electrophoresis, with 73–85% recovery and maintenance of their size, negative zeta potential, and CD41 and CD61 expression. Interestingly, the EVs purified from the four HPLs exhibited a differential capacity to promote cell growth and migration in a wound-healing assay using SH-SY5Y neuronal cells, and one EV preparation stimulated network formation in primary neuronal cultures. These data indicated that the EVs present in HPLs have different neuroregenerative capacities and that some EV preparations may have interesting applications as a stand-alone therapy for usage in neuroregenerative medicine.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (107-2314-B-038- 084, 110-2314-B-038-079)
This publication has 79 references indexed in Scilit:
- Proteome Profiling of Neuroblastoma-Derived Exosomes Reveal the Expression of Proteins Potentially Involved in Tumor ProgressionPLOS ONE, 2013
- Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factorsStem Cell Research & Therapy, 2013
- Extracellular vesicles as an emerging mechanism of cell-to-cell communicationEndocrine, 2012
- Platelet-Derived Microvesicles: Multitalented Participants in Intercellular CommunicationSeminars in Thrombosis and Hemostasis, 2012
- Apheresis platelet concentrates contain platelet‐derived and endothelial cell‐derived microparticlesVox Sanguinis, 2011
- Novel test for microparticles in platelet‐rich plasma and platelet concentrates using dynamic light scatteringTransfusion, 2010
- Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein AggregatesPharmaceutical Research, 2010
- Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)Trends in Biotechnology, 2009
- What do we use: Platelet‐rich plasma or platelet‐leukocyte gel?Journal of Biomedical Materials Research Part A, 2007
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007